Eli Lilly stock rises after late-stage trial of next-generation weight-loss drug

9 June 2026 Last updated : 9 June 2026 BonTrade
Eli Lilly shares gained on Monday, after a late-stage trial of its next-generation weight-loss drug impressed analysts.
Categories
BonTrade News
Previous article
Micron’s stock bounces back in a big way: ‘The memory trade is alive and well’New!!
9 June 2026
Next article
‘I have no experience with investing’: I inherited $2,000. I’m 42 with two children. What should I do with this money?New!!
9 June 2026